View Item 

A Case Report of Gastrointestinal Basidiobolomycosis Treated With Voriconazole: A Rare Emerging Entity

Access Status
Open access
Authors
Al-Naemi, A.
Khan, L.
Al-Naemi, I.
Amin, K.
Athlawy, Y.
Awad, A.
Sun, Zhonghua
Date
2015
Type
Journal Article

Metadata
Show full item record
Citation
Al-Naemi, A. and Khan, L. and Al-Naemi, I. and Amin, K. and Athlawy, Y. and Awad, A. and Sun, Z. 2015. A Case Report of Gastrointestinal Basidiobolomycosis Treated With Voriconazole: A Rare Emerging Entity. Medicine (Baltimore). 94 (35): pArticle ID e1430
Source Title
Medicine (Baltimore)
DOI
School
Department of Medical Radiation Sciences
Remarks

This open access article is distributed under the Creative Commons license http://creativecommons.org/licenses/by-nd/4.0

URI
Collection
Abstract

Introduction: Basidiobolomycosis is an unusual fungal disease that rarely involves the visceral organs such as gastrointestinal tract. Gastrointestinal basidiobolomycosis (GIB) has been increasingly reported in the literature, and it is an emerging disease from arid regions worldwide, in particular, the south-western Saudi Arabia. We report a case of GIB in a 36-year-old Saudi Arabian male patient showing resistance to itraconazole and best treated with voriconazole. Computed tomography showed diffusely thickened small bowel with edematous change. Conclusions: As GIB presents diagnostic challenges due to lack of specific features, this case emphasizes the importance of considering GIB in the differential diagnosis in patients presenting with fever, abdominal pain with fast-growing abdominal mass.